Alexander Morokutti - Concepedia

Author

Alexander Morokutti

Medical University of Vienna ORCID

Also Known As

A. Morokutti, Alexander Morokutti

Publications

418

Citations

H-Index

Concepts

All Affiliations

Medical University of Vienna Goethe University Frankfurt BOKU University Research Institute of Influenza

About

Alexander Morokutti is an author at Medical University of Vienna specializing in medicine, vaccination, and influenza vaccines.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	263
2	Immunology	5	5	263
3	Vaccine Development	4	4	244
4	Immunotherapy	1	1	19
5	Viral Immunity	1	1	130

Alexander Morokutti

Publications

418

Citations

H-Index

Page 1

	Year	Citations
A Novel Type of Influenza Vaccine: Safety and Immunogenicity of Replication‐Deficient Influenza Virus Created by Deletion of the Interferon Antagonist NS1 Volker Wacheck, Andrej Egorov, Franz Groiss, The Journal of Infectious Diseases VaccinationVaccine SafetyAdverse EventsInterferon Antagonist Ns1Vaccine Development	2009	130
Single HA2 Mutation Increases the Infectivity and Immunogenicity of a Live Attenuated H5N1 Intranasal Influenza Vaccine Candidate Lacking NS1 Brigitte M. Krenn, Andrej Egorov, Ekaterina Romanovskaya-Romanko, PLoS ONE	2011	83
Preclinical Evaluation of a Replication-Deficient Intranasal ΔNS1 H5N1 Influenza Vaccine Julia Romanova, Brigitte M. Krenn, Markus Wolschek, PLoS ONE	2009	72
Mutations affecting the stability of the haemagglutinin molecule impair the immunogenicity of live attenuated H3N2 intranasal influenza vaccine candidates lacking NS1 Sabine Nakowitsch, Markus Wolschek, Alexander Morokutti, Vaccine VaccinationVaccine DevelopmentImmunologyVirologyInfluenza Vaccine	2011	40
Intranasal vaccination with a replication-deficient influenza virus induces heterosubtypic neutralising mucosal IgA antibodies in humans Alexander Morokutti, Thomas Muster, Boris Ferko Vaccine VaccinationMucosal VaccinationVaccine DevelopmentImmunologyVirology	2014	39
Development of a live-attenuated influenza B ΔNS1 intranasal vaccine candidate Nina Wressnigg, Thorsten Wolff, Julia Romanova, Vaccine VaccinationVaccine DevelopmentImmunologyVirologyInfluenza Vaccine	2009	35
Validation of the modified hemagglutination inhibition assay (mHAI), a robust and sensitive serological test for analysis of influenza virus-specific immune response Alexander Morokutti, Monika Redlberger‐Fritz, Sabine Nakowitsch, Journal of Clinical Virology VaccinationViral DiagnosticsSensitive Serological TestImmunologySerologic Testing	2013	19

Page 1